Lamura E, Hillier K, Kinkaid A, Wilton D
Clinical Pharmacology Group, University of Southampton, UK.
Biochem Pharmacol. 1997 May 9;53(9):1323-32. doi: 10.1016/s0006-2952(96)00883-0.
The biochemical properties of the phospholipase A2 (PLA2) found in the 100,000 x g centrifugate cytosol or particulate fractions of human colonic mucosa have been investigated using both deoxycholate-solubilized and Escherichia coli (E. coli) phospholipids as substrates. PLA2 activity was present in both subcellular fractions and the profiles of biochemical activites were similar. Activity in the particulate fraction was approximately twofold greater than the cytosol fraction when expressed on the basis of protein concentration. The PLA2 is Ca2+ dependent and using EGTA-regulated buffers cytosolic or particulate fraction activity was similar at both 10 microm or 10 mm Ca2+ concentrations. Using deoxycholate-phospholipid micelles as substrate a small but statistically significant twofold preference for glycero-phosphatidylcholine bearing sn-2-arachidonate compared with sn-2-oleate was seen, but this preference was not noted using arachidonate or oleate labelled E. coli membranes. Dithiothreitol (10 mM) reduced colon mucosal cytosol PLA2 activity significantly by 63.5 +/- 1.90% in cytosol and by 30.54 +/- 1.27% in microsomes using micelles as substrate or by 84.3 +/- 2.30% in cytosol and by 69.33 +/- 11.30% in microsomes using oleate-labelled E. coli as substrates. Warming at 57 degrees C reduced activity significantly by 35.0 +/- 5.80% in microsomes and by 40.0 +/- 7.08% in cytosol. Acid treatment increased PLA2 activity to 148 +/- 16.3% in microsomes and 145 +/- 18.6% in cytosol. When mucosal preparations were subjected to heparin-Sepharose chromatography, it bound tightly and eluted in the same position on a salt gradient as authentic human group II PLA2. Further purification by gel-permeation chromatography gave activity in the 14 kDa region of the elution profile. These features have many of the characteristics expected of a 14 kDa isoform of PLA2 but exhibit activity at concentrations of Ca2+ that are relevant in the intracellular environment and may participate in cellular lipid metabolism.
利用脱氧胆酸盐增溶的磷脂和大肠杆菌(E. coli)磷脂作为底物,对人结肠黏膜100,000×g离心所得的胞质溶胶或微粒体部分中发现的磷脂酶A2(PLA2)的生化特性进行了研究。PLA2活性存在于两个亚细胞部分,且生化活性谱相似。以蛋白质浓度为基础表示时,微粒体部分的活性比胞质溶胶部分大约高两倍。PLA2依赖Ca2+,使用EGTA调节缓冲液时,在10微摩尔或10毫摩尔Ca2+浓度下,胞质溶胶或微粒体部分的活性相似。以脱氧胆酸盐 - 磷脂微团作为底物时,与sn - 2 - 油酸相比,对带有sn - 2 - 花生四烯酸的甘油磷脂酰胆碱有轻微但在统计学上有显著意义的两倍偏好,但使用花生四烯酸或油酸标记的大肠杆菌膜时未观察到这种偏好。使用微团作为底物时,二硫苏糖醇(10 mM)可使结肠黏膜胞质溶胶PLA2活性显著降低,胞质溶胶中降低63.5±1.90%,微粒体中降低30.54±1.27%;使用油酸标记的大肠杆菌作为底物时,胞质溶胶中降低84.3±2.30%,微粒体中降低69.33±11.30%。在57℃加热可使微粒体活性显著降低35.0±5.80%,胞质溶胶活性降低40.0±7.08%。酸处理可使微粒体中PLA2活性增加至148±16.3%,胞质溶胶中增加至145±18.6%。当黏膜制剂进行肝素 - 琼脂糖层析时,它紧密结合,并在盐梯度上与真正的人II型PLA2在相同位置洗脱。通过凝胶渗透层析进一步纯化后,在洗脱图谱的14 kDa区域出现活性。这些特征具有预期的14 kDa PLA2同工型的许多特性,但在与细胞内环境相关的Ca2+浓度下表现出活性,可能参与细胞脂质代谢。